Rahman, Mohummad Aminur
Gras Navarro, Andrea
Brekke, Jorunn
Engelsen, Agnete
Bindesbøll, Christian
Sarowar, Shahin
Bahador, Marzieh
Bifulco, Ersilia
Goplen, Dorota
Waha, Andreas
Lie, Stein Atle
Gjertsen, Bjørn Tore
Selheim, Frode
Enger, Per Øyvind
Simonsen, Anne
Chekenya, Martha
Article History
Received: 26 April 2019
Revised: 10 July 2019
Accepted: 25 July 2019
First Online: 15 August 2019
Competing interests
: The authors declare no competing interests.
: The regional ethical committee (REK Vest) and The Norwegian Data Protection Agency approved the establishment of a brain tumour and blood biobank (REK Vest 013.09/20879) and issued project approval. Patients provided informed consent for use of their tissue samples for research purposes (REK2018/71). All animal procedures were performed in accordance with the European Convention for the Protection of Vertebrates Used for Scientific purposes, [Scientific Procedures] Act 1986. The study protocols were approved by The Norwegian Animal Research Authority (Oslo, Norway, FOTS ID 9460). The study was performed in accordance with the Declaration of Helsinki.
: We are grateful to the Norwegian Research Council (FRIMEDBIO grant #230691 to M.C. and grant #221831 to C.B. and A.S. and partial support by its Centres of Excellence funding scheme, project number 262652 to A.S.), the University of Bergen (M.C. and A.G.N.), Meltzer Fond (to M.C.) and the Norwegian Cancer Society (grants #6786380 and #190170 M.C. and #171318, A.S.) for supporting our research.
: All authors read and consented to publication of the final version of the paper.
: The mass spectrometry proteomics data and files have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository<sup>47</sup> with the dataset identifier PXD007193. Western blot and other data sets used and/or analysed during this study are available from the corresponding author on reasonable request.